国会已经做好准备,开始对一个全面的生物医学创新法案投票表决。该法案包括美国国立卫生研究院(NIH)的3项研究计划,涉及专用资助金额近50亿美元;该法案还包括针对美国食品与药品监督管理局(FDA)提出的加快新药和新医疗器械审批的措施。该法案将会创建一种机制,努力精简那些被大学和学术人员当成负担的联邦法规。这项代表两党的法案被称为《21世纪治愈法案》,是研究者、病人和产业团体经过两年多游说, Congress is ready to begin voting on a comprehensive biomedical innovation bill. The bill includes three research projects from the National Institutes of Health (NIH) involving nearly $ 5 billion in earmarked funding. The act also includes a proposal to speed up the approval of new drugs and new medical devices by the U.S. Food and Drug Administration The measure. The bill will create a mechanism that strives to streamline federal regulations that are burdened by universities and academics. This bill representing both parties is known as the Cure for the 21st Century. After more than two years of lobbying by researchers, patients and industrial groups,